|Bid||0.6102 x 1300|
|Ask||0.7000 x 900|
|Day's Range||0.6255 - 0.6999|
|52 Week Range||0.5800 - 2.7400|
|Beta (5Y Monthly)||1.61|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 15, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||3.76|
Subscribe to Yahoo Finance Plus to view Fair Value for VNRX
NEW YORK, NY / ACCESSWIRE / December 5, 2023 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day December Small-Cap Conference taking place Wednesday and Thursday, December ...
VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has closed on an aggregate of Euro 5.0 million (approximately $5.5 million) in financing from Wallonie Entreprendre S.A. ("WE") in Belgium.
VolitionRx Limited (AMEX:VNRX) Q3 2023 Earnings Call Transcript November 15, 2023 Operator: Good morning, ladies and gentlemen. Thank you for standing by. Welcome to VolitionRx Limited Third Quarter 2023 Earnings Conference Call. During today’s presentation, all parties will be in a listen-only mode. Following the presentation, the conference call will be opened for questions. [Operator […]